Skip to main content

Vitiligo clinical trials at UCSF

1 research study open to eligible people

Showing trials for
  • Assess the Long Term Efficacy and Safety of Ruxolitinib Cream in Participants With Vitiligo

    open to eligible people ages 12 years and up

    The purpose of this study is to evaluate the duration of response following withdrawal of ruxolitinib cream (Cohort A vehicle group), safety and maintenance of response with continued use of ruxolitinib cream in participants who have completed either Study NCT04052425 or NCT04057573 (parent studies) in which the participants will have been using ruxolitinib cream BID for the previous 28 to 52 weeks depending on their initial randomization in the parent study.

    San Francisco, California and other locations

Last updated: